Coherus Biosciences Inc (CHRS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CHRS? Forum Prognose

Finanzdaten der Coherus Biosciences Inc-Aktie (CHRS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	15.80% 77.06	91.52	74.57	58.72	32.44
Cost Of Revenue	59.10% 34.59	84.57	32.70	24.85	16.87
Gross Profit	510.56% 42.48	6.957	41.87	33.87	15.56
Operating Expenses	12.05% 85.00	75.86	73.87	68.41	83.31
Interest Income/Expense	4.68% 11.12	10.62	10.27	9.943	9.712
Benefits Costs and Expenses	115.08% -25.81	171.18	114.59	101.58	108.17
Costs And Expenses	25.46% 119.59	160.43	106.57	93.26	100.18
Depreciation and Amortization	41.77% 1.507	1.063	0.899	0.88	0.949
Operating Income/Loss	38.28% -42.52	-68.91	-32.01	-34.54	-67.75
Income/Loss From Continuing Operations Before Tax	229.15% 102.88	-79.65	-40.02	-42.87	-75.73
Income/Loss From Continuing Operations After Tax	229.15% 102.88	-79.65	-39.64	-42.87	-75.73
Net Income/Loss	229.15% 102.88	-79.65	-39.64	-42.87	-75.73
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,816% 112.75	5.8847	97.74	87.27	79.27
Diluted Average Shares	2,033% 125.53	5.8847	97.74	87.27	79.27
Basic Earnings Per Share	222.97% 0.91	-0.74	-0.41	-0.49	-0.96
Diluted Earnings Per Share	212.16% 0.83	-0.74	-0.41	-0.49	-0.96
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%